Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia
Open Access
- 15 January 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (2), 268-274
- https://doi.org/10.1093/cid/cir838
Abstract
In view of the alarming spread of antimicrobial resistance in the absence of new antibiotics, this study aimed at assessing the availability of potentially useful older antibiotics. A survey was performed in 38 countries among experts including hospital pharmacists, microbiologists, and infectious disease specialists in Europe, the United States, Canada, and Australia. An international expert panel selected systemic antibacterial drugs for their potential to treat infections caused by resistant bacteria or their unique value for specific criteria. Twenty-two of the 33 selected antibiotics were available in fewer than 20 of 38 countries. Economic motives were the major cause for discontinuation of marketing of these antibiotics. Fourteen of 33 antibiotics are potentially active against either resistant Gram-positive or Gram-negative bacteria. Urgent measures are then needed to ensure better availability of these antibiotics on a global scale.Keywords
This publication has 10 references indexed in Scilit:
- Efforts to Support the Development of Fusidic Acid in the United StatesClinical Infectious Diseases, 2011
- Combating Antimicrobial Resistance: Policy Recommendations to Save LivesClinical Infectious Diseases, 2011
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspectiveDrug Resistance Updates, 2011
- Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is nowDrug Resistance Updates, 2011
- Kucers' The Use of AntibioticsPublished by Informa UK Limited ,2010
- Save antibiotics. What can be done to prevent a forecasted disaster! Suggestions to promote the development of new antibioticsMedecine Et Maladies Infectieuses, 2010
- Role of Old Antibiotics in Multidrug Resistant Bacterial InfectionsCurrent Drug Targets, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Temocillin revivedJournal of Antimicrobial Chemotherapy, 2008
- All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistanceClinical Microbiology & Infection, 2008